about
Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives.In vitro study of uptake and synthesis of creatine and its precursors by cerebellar granule cells and astrocytes suggests some hypotheses on the physiopathology of the inherited disorders of creatine metabolism.Validation of a simple method for atrial fibrillation screening in patients with stroke.Systemic administration of mesenchymal stem cells increases neuron survival after global cerebral ischemia in vivo (2VO).Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease.Effects on Energy Metabolism of Two Guanidine Molecules, (Boc)2 -Creatine and Metformin.Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients.Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.Support of Nerve Conduction by Respiring Myelin Sheath: Role of Connexons.Creatine salts provide neuroprotection even after partial impairment of the creatine transporter.A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity.Kinetics of creatine in blood and brain after intraperitoneal injection in the rat.Churg-Strauss syndrome mimicking myocardial infarction with cerebral vascular involvement.The neuroprotective effect of creatine in rats with cerebral ischemia.Electrophoretic characterization of gold nanoparticles functionalized with human serum albumin (HSA) and creatine.Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency.Safe and effective outcome of intravenous thrombolysis for acute ischemic stroke in patients aged 90 years or older.Structural organization of astrocytes in the rat hippocampus in the post-ischemic period.Activation of cerebellar granule cells GABA(A) receptors by guanidinoacetate.Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency.Sex differences in human lymphocyte Na,K-ATPase as studied by labeled ouabain binding.Resuming anticoagulation after brain hemorrhage while on warfarin treatment: INR at the time of bleeding should be taken into consideration.Searching for a therapy of creatine transporter deficiency: some effects of creatine ethyl ester in brain slices in vitro.A Novel Method to Synthesize Phosphocreatine and Phosphocreatine Prodrugs.Electrophysiological recording of re-aggregating brain cell cultures on multi-electrode arrays to detect acute neurotoxic effects.Handwriting as a gauge of cognitive status: a novel forensic tool for posthumous evaluation of testamentary capacity.Delirium in the acute phase after stroke: comparison between methods of detection.A new method to synthesize creatine derivatives.Bone Marrow-Derived Progenitor Cells in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyA Novel Hypothesis About Mechanisms Affecting Conduction Velocity of Central Myelinated FibersBannwarth syndrome: report of two casesThe antiepileptic effect of low-dose amino-phosphono-valeric acid (APV) is not enhanced by phosphatidylserine associationWhite blood cell count and erythrocyte sedimentation rate correlate with outcome in patients with acute ischemic strokeAngioedema after rt-PA treatment in acute ischemic stroke may be attended by shock and worsening of stroke outcomeSafety and efficacy even after 90 years of age should prompt removal of upper age limits in systemic thrombolysis for strokeBeyond sports: Efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and musclePresence of guanidinoacetate may compensate creatine absence and account for less statin-induced muscle damage in GAMT-deficient compared to AGAT-deficient miceThe Good, the Bad, and the Ugly: Not All Supplements Are EqualStatin-induced myopathy prevented by creatine administration
P50
Q34089086-C7C6CFDE-62AA-4D0C-A7FB-8A0B38A5D5D7Q34247638-73289824-E744-47E3-BF78-0A4ECEF81DEBQ34474337-56CC6345-F7B5-4EB5-AD87-58E52BA58F85Q34575387-A0EBECF2-3BF8-4466-8887-95CA796B38FEQ38706110-26BF23FB-F749-488E-AB0A-877C8A8179EAQ38719175-11C5C850-2D28-4231-85C5-B89ADAFD58ABQ39162475-95CC0611-F164-4CA3-96CD-1CB8D2F7DA55Q40202728-37BD6CDB-B557-468E-BD01-5A31930E365FQ40880201-026865EA-6E94-4ADD-B69B-AAEBC2929502Q41565439-4F6614B2-BD9B-4211-8CE5-924D97446593Q42357779-0A9BB462-7A3D-4804-96E4-151DB1EE588BQ44438162-8F721501-4103-4BD7-9338-D9217FBE1C62Q44532147-94C33437-7C38-469A-98AD-8B706CF9E40CQ44562785-B1EA6F3D-7CE0-4FB3-BE77-ACA5060F30DFQ45248154-0AFECF33-D9EF-445F-864F-06A0DF2BE760Q46008287-8EED6992-2101-4B12-AA35-5ADA96EC5AC2Q46319561-A83D017A-1E2D-4069-9D5A-9C5885BFD04DQ46521917-32C94090-8BF0-4184-A458-975DB2395411Q46789696-AF3AEFAC-A369-40AD-904A-2FDD44ADF4DBQ47921416-59C11E46-B71F-43CE-B158-8F5AE5D87BA9Q48238761-B081A89C-6829-49D9-B41E-E922A5687D7FQ48312675-5BBA48F4-A5FB-4691-AAB9-15ADC6363AA7Q48868675-8C36F197-08F3-459C-990E-C12CC45D40EBQ49817530-D7099969-50AA-442F-ABAA-955A366B4CC1Q50937953-F15B73DA-54F5-4AF0-A568-0A5914C3FCE9Q51878701-007CF180-8D67-45F9-84F5-BDBC1EEAA283Q53533491-DCB1941B-6153-454C-8B3F-9E4B9AC629FDQ54426699-E98C1EEC-5C89-4D29-905A-D250531966B0Q59714794-0560A5E7-0565-4C7F-9BE2-91E283F753DFQ61733129-AFDA2872-3DAA-4AE8-B2D7-4FFD8E08FD89Q70201833-6ACC5130-146A-4547-AB90-66E48FD7C32EQ72675369-E3607C90-BB46-4820-AF4C-D49E3F474F8FQ81351514-B481DA1D-5886-4387-852A-3D91B1109E46Q87428662-B46E8F8E-2CE0-4C35-8729-AB90064AEE51Q88090065-8A241CA8-D9BC-4B8F-ACB3-52D344C28C4EQ90221760-02F342B7-75D2-4D1B-A6CD-693109C26543Q90330894-049399BC-B534-4745-BDB1-302462634681Q90927174-6444B90E-618B-4668-BE34-8B771253DF66Q91164744-9B0AC402-D6B9-4B49-B760-74774285C913
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5971-2200
@en
name
Maurizio Balestrino
@ast
Maurizio Balestrino
@en
Maurizio Balestrino
@es
Maurizio Balestrino
@nl
type
label
Maurizio Balestrino
@ast
Maurizio Balestrino
@en
Maurizio Balestrino
@es
Maurizio Balestrino
@nl
prefLabel
Maurizio Balestrino
@ast
Maurizio Balestrino
@en
Maurizio Balestrino
@es
Maurizio Balestrino
@nl
P106
P31
P496
0000-0002-5971-2200